0001127602-14-018510.txt : 20140522
0001127602-14-018510.hdr.sgml : 20140522
20140522171538
ACCESSION NUMBER: 0001127602-14-018510
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140521
FILED AS OF DATE: 20140522
DATE AS OF CHANGE: 20140522
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMGEN INC
CENTRAL INDEX KEY: 0000318154
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 953540776
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
BUSINESS PHONE: (805)447-1000
MAIL ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
FORMER COMPANY:
FORMER CONFORMED NAME: AMGEN
DATE OF NAME CHANGE: 19870305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dittrich Thomas J.W.
CENTRAL INDEX KEY: 0001491654
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-12477
FILM NUMBER: 14864532
MAIL ADDRESS:
STREET 1: AMGEN INC.
STREET 2: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320-1799
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2014-05-21
0000318154
AMGEN INC
AMGN
0001491654
Dittrich Thomas J.W.
ONE AMGEN CENTER DRIVE
THOUSAND OAKS
CA
91320
1
VP, Finance & CAO
Common Stock
2014-05-21
4
M
0
1980
54.69
A
20569
D
Common Stock
2014-05-21
4
M
0
2150
58.43
A
22719
D
Common Stock
2014-05-21
4
S
0
4130
112.829
D
18589
D
Nqso (Right to Buy)
54.69
2014-05-21
4
M
0
1980
0
D
2013-04-25
2021-04-25
Common Stock
1980
2040
D
Nqso (Right to Buy)
58.43
2014-05-21
4
M
0
2150
0
D
2011-04-26
2020-04-26
Common Stock
2150
0
D
The price reported is an average price. The prices ranged from $112.82 to $112.86 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer.
The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 583 RSUs which vest in one installment of 583 on 4/25/2015; 938 RSUs which vest in two installments of 462 on 4/27/2015 and 476 on 4/27/2016; 942 RSUs which vest in annual installments of 310, 311 and 321 on 4/26/2015, 4/26/2016 and 4/26/2017, respectively; and 681 RSUs which vest in annual installments of 224, 225 and 232 on 4/25/2015, 4/25/2017 and 4/25/2018, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
These shares include 40 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
/s/ Thomas J.W. Dittrich
2014-05-21